What are the interventions for essential tremors induced by aripiprazole (Abilify)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Aripiprazole-Induced Essential Tremor

For aripiprazole-induced tremor, the first-line intervention is to discontinue the offending medication if clinically possible, followed by propranolol (40mg twice daily) if tremor persists or if aripiprazole cannot be discontinued. 1

Diagnostic Approach

When evaluating medication-induced tremor from aripiprazole:

  • Confirm the temporal relationship between aripiprazole initiation and tremor onset
  • Evaluate tremor characteristics (postural, action, rest)
  • Rule out other potential causes through basic metabolic panel, liver function, thyroid function, calcium, and HbA1c tests 1

Management Algorithm

Step 1: Medication Adjustment

  • If possible, discontinue aripiprazole after psychiatric consultation 1
  • Consider switching to an alternative antipsychotic with lower risk of extrapyramidal symptoms
  • If aripiprazole must be continued due to psychiatric necessity, proceed to pharmacological management

Step 2: Pharmacological Management

  1. First-line treatment: Propranolol

    • Starting dose: 40mg twice daily
    • May titrate up to 240mg daily based on response
    • Efficacy: Approximately 50% of patients respond 1, 2
    • Monitor for bradycardia, hypotension, fatigue, and bronchospasm
  2. Alternative beta-blockers (if propranolol not tolerated):

    • Metoprolol: Less effective but safer for patients with respiratory concerns
    • Atenolol: Fewer central nervous system effects
    • Nadolol: Alternative option with different side effect profile 1
  3. Second-line options (if beta-blockers inadequate or contraindicated):

    • Gabapentin: 300-2400mg daily divided into three doses 1
    • Primidone: Starting at low doses (12.5-25mg) and gradually titrating 3, 2
    • Alprazolam: 0.75mg daily (particularly effective for elderly patients) 4

Step 3: For Refractory Tremor

  • Consider combination therapy (beta-blocker + primidone or gabapentin) 1, 2
  • For severe, disabling tremor unresponsive to medications:
    • Deep brain stimulation (DBS) of the thalamus (~90% tremor control) 3, 2
    • MR-guided focused ultrasound (MRgFUS) thalamotomy (56% tremor improvement maintained at 4 years) 3

Special Considerations

  • In elderly patients: Start with lower doses of propranolol (10-20mg twice daily) and titrate slowly 1
  • With respiratory conditions: Avoid propranolol; consider metoprolol or non-beta blocker options 1
  • With anxiety: Alprazolam may provide dual benefit 4
  • With neuropathic pain: Gabapentin may be preferred 1

Monitoring and Follow-up

  • Assess treatment response using standardized tremor rating scales
  • Monitor for side effects specific to the chosen medication
  • Evaluate for potential drug interactions, particularly with psychiatric medications
  • Consider quality of life impact when selecting treatment options 1

Important Caveats

  • Medication-induced tremors typically improve when the offending medication is discontinued
  • If aripiprazole must be continued for psychiatric stability, tremor management becomes more challenging
  • Surgical interventions should only be considered for severe, disabling tremor that is unresponsive to multiple medication trials 3
  • The benefit-risk ratio must be carefully considered, as approximately 50% of patients respond to pharmacological treatments 2, 5

References

Guideline

Tremor Evaluation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

New alternative agents in essential tremor therapy: double-blind placebo-controlled study of alprazolam and acetazolamide.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.